Physical Medicine & Rehabilitation, Pain Medicine · Long Beach, CA
NPI
1770715575
Since 2009
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
3939 Atlantic Ave Ste 223
Long Beach, CA, 90807
Phone (562) 633-1765
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
366 services
Medicare patients, 2024
48
Average age 68
Drug cost, 2024
$249K
947 prescriptions
Company payments, 2025
$203
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrei N Dokukin was code 99213 (office e&m - established), 350 times for 45 patients. In total Andrei N Dokukin billed 366 services in 7 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 350 | 45 | $75.92 | $27K |
By year: 2022 $30K for 407 services; 2023 $29K for 408 services; 2024 $28K for 366 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrei N Dokukin prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 258 prescriptions and refills. In total Andrei N Dokukin wrote 947 Medicare prescriptions that cost $249K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 258 | 258 | 34 | $48K |
| Buprenorphine Hcl Generic | 135 | 135 | 19 | $6,285 |
| Gabapentin Generic | 82 | 85 | 12 | $465 |
| Quetiapine Fumarate Generic | 57 | 57 | Under 11 | $530 |
| Fluoxetine Hcl Generic | 48 | 48 | Under 11 | $86.48 |
| Pregabalin Generic | 39 | 43 | Under 11 | $982 |
| Levorphanol Tartrate Generic | 29 | 29 | Under 11 | $78K |
| Ibuprofen Generic | 27 | 27 | Under 11 | $82.84 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 26 | 26 | Under 11 | $755 |
| Zipsor Diclofenac Potassium | 17 | 17 | Under 11 | $7,590 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 17 | 17 | Under 11 | $10K |
| Ondansetron Hcl Generic | 17 | 17 | Under 11 | $288 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 17 | 17 | Under 11 | $369 |
| Trazodone Hcl Generic | 16 | 18 | Under 11 | $73.29 |
| Lyrica Pregabalin | 13 | 13 | Under 11 | $12K |
Brand drugs: - claims; generic drugs: 844 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrei N Dokukin $203 ($203 in general payments such as food, travel and fees) from 1 company. The largest payer was Braeburn Inc. with $203.
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 4 | $203 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.